Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
-0.763 %
$ 75.1 M
Market Cap
-0.87
P/E
AVTE - OPERATING EXPENSES
Operating Expenses AVTE - Aerovate Therapeutics, Inc.
81.4 M
LAST VALUE
88.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR